Digital marketing and technology agency Valtech hires Leanne Khor in the role of business partner

| | No Comments

Leanne Khor, Valtech (2).jpgGlobal digital marketing and technology agency Valtech has announced another senior appointment for its Australian operations, with Leanne Khor joining the company as business partner.

In this newly created role as business partner, Khor will be responsible for growing and managing Valtech’s expertise and capabilities in three of its six core service offerings – CX strategy, content and campaigns and data services. She will also work closely alongside the company’s strategic partner, Adobe.

Khor brings more than ten years of experience in the marketing and digital sector to Valtech, having most recently been director of operations and delivery at 2DataFish where she was a member of the leadership team and was responsible for driving and executing on strategic business growth plans for the business.

Says Khor: “Valtech is truly a globally-connected agency and I’ve been genuinely impressed with my initial connections across APAC and beyond. I am really looking forward to bringing global and regional expertise, digital best-practice and genuine success stories to our Australian clients.”

This latest appointment follows a number of recent hires, including new Valtech Australia MD Andrew Davenport who was formerly MD of The White Agency. The senior hires underpin the company’s strategy to increase focus on the APAC region and drive the Valtech global offer in the Australian market.

Says Davenport: “We are focused on replicating Valtech’s international success and business growth by driving the global offer here in Australia. Leanne’s appointment will help enable us to achieve this as she brings a rare mix of experience in both client management, operations and delivery.”

Valtech addresses transformational business challenges for clients across the world. Valtech’s global client list includes L’Oreal, Louis Vuitton, Audi, BMW and Novartis, while locally clients include TAL, ACS, Ego Pharmaceuticals and Foxtel.